Exome Asset Management LLC 13F holdings, Q1 2025
Holdings as of March 31, 2025 · filings on SEC EDGAR · latest filing →
Exome Asset Management LLC disclosed 49 US equity positions worth $111.6m in its Q1 2025 13F filing. The largest position was BBIO at 5.1% of the reported book, followed by GH and GERN. Against the Q4 2024 filing, it opened 15 new positions, added to 14 and reduced 14 among the top 49 holdings.
What did Exome Asset Management LLC own in Q1 2025? Top 49 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q4 2024 |
|---|---|---|---|---|---|---|---|
| 1 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 5.1% | $5.7m | 165,496 | -33% | reduced |
| 2 | GH GUARDANT HEALTH INC | Healthcare | 4.9% | $5.4m | 127,182 | -14% | reduced |
| 3 | GERN GERON CORP | Healthcare | 4.6% | $5.1m | 3,215,457 | 106% | added |
| 4 | AZN ASTRAZENECA PLC | Healthcare | 4.2% | $4.7m | 32,534 | – | new |
| 5 | CYTK CYTOKINETICS INC | Healthcare | 3.7% | $4.2m | 103,483 | 57% | added |
| 6 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 3.7% | $4.1m | 337,198 | 6% | added |
| 7 | IONS IONIS PHARMACEUTICALS INC | Healthcare | 3.7% | $4.1m | 135,616 | 121% | added |
| 8 | LLY ELI LILLY & CO | Healthcare | 3.5% | $3.9m | 4,673 | -43% | reduced |
| 9 | COGT COGENT BIOSCIENCES INC | Healthcare | 3.3% | $3.7m | 621,678 | – | new |
| 10 | ISRG INTUITIVE SURGICAL INC | Healthcare | 2.8% | $3.1m | 6,358 | -14% | reduced |
| 11 | SLNOEUR SOLENO THERAPEUTICS INC | 2.8% | $3.1m | 43,441 | -44% | reduced | |
| 12 | AKERO THERAPEUTICS INC | 2.8% | $3.1m | 76,379 | 11% | added | |
| 13 | IRON DISC MEDICINE INC | Healthcare | 2.7% | $3.1m | 61,656 | -11% | reduced |
| 14 | VRDN VIRIDIAN THERAPEUTICS INC | Healthcare | 2.6% | $2.9m | 217,294 | – | new |
| 15 | RGNX REGENXBIO INC | Healthcare | 2.6% | $2.9m | 405,281 | – | new |
| 16 | REPL REPLIMUNE GROUP INC | Healthcare | 2.6% | $2.9m | 294,846 | 439% | added |
| 17 | SRRK SCHOLAR ROCK HLDG CORP | Healthcare | 2.4% | $2.7m | 84,339 | 9% | added |
| 18 | DYN DYNE THERAPEUTICS INC | Healthcare | 2.4% | $2.7m | 258,391 | – | new |
| 19 | NTRA NATERA INC | Healthcare | 2.4% | $2.6m | 18,650 | -17% | reduced |
| 20 | ETNBGBP 89BIO INC | 2.3% | $2.6m | 353,882 | 57% | added | |
| 21 | PEN PENUMBRA INC | Healthcare | 2.2% | $2.4m | 9,000 | 0% | held |
| 22 | SVRA SAVARA INC | Healthcare | 2.1% | $2.3m | 836,397 | 20% | added |
| 23 | ANAB ANAPTYSBIO INC | Healthcare | 1.9% | $2.2m | 116,623 | – | new |
| 24 | TVTX TRAVERE THERAPEUTICS INC | Healthcare | 1.9% | $2.1m | 118,017 | – | new |
| 25 | CNTA CENTESSA PHARMACEUTICALS PLC | 1.8% | $2.1m | 142,744 | 4% | added | |
| 26 | GEHC GE HEALTHCARE TECHNOLOGIES I | Healthcare | 1.8% | $2.1m | 25,400 | – | new |
| 27 | FULC FULCRUM THERAPEUTICS INC | Healthcare | 1.8% | $2.0m | 689,137 | 143% | added |
| 28 | GPCR STRUCTURE THERAPEUTICS INC | Healthcare | 1.6% | $1.8m | 102,944 | -32% | reduced |
| 29 | IMNM IMMUNOME INC | Healthcare | 1.6% | $1.8m | 263,841 | – | new |
| 30 | ONC BEIGENE LTD | Healthcare | 1.6% | $1.8m | 6,500 | -35% | reduced |
| 31 | CRNXGBP CRINETICS PHARMACEUTICALS IN | 1.5% | $1.7m | 51,295 | – | new | |
| 32 | EWTX EDGEWISE THERAPEUTICS INC | 1.4% | $1.6m | 71,438 | -12% | reduced | |
| 33 | RDY DR REDDYS LABS LTD | Healthcare | 1.4% | $1.5m | 117,500 | 0% | held |
| 34 | CRBP CORBUS PHARMACEUTICALS HLDGS | Healthcare | 1.4% | $1.5m | 289,690 | – | new |
| 35 | KARYOPHARM THERAPEUTICS INC | 1.4% | $1.5m | 2,000,000 | 0% | held | |
| 36 | NKTR NEKTAR THERAPEUTICS | Healthcare | 1.4% | $1.5m | 2,232,453 | 261% | added |
| 37 | ARVN ARVINAS INC | Healthcare | 1.2% | $1.4m | 195,295 | -11% | reduced |
| 38 | GOSS GOSSAMER BIO INC | Healthcare | 1.1% | $1.2m | 1,097,999 | 0% | held |
| 39 | TRVI TREVI THERAPEUTICS INC | Healthcare | 0.9% | $1.0m | 163,738 | – | new |
| 40 | MBX MBX BIOSCIENCES INC | Healthcare | 0.9% | $982.4k | 133,113 | – | new |
| 41 | BHVN BIOHAVEN LTD | Healthcare | 0.9% | $959.2k | 39,900 | 42% | added |
| 42 | ALVOTECH | 0.8% | $871.3k | 90,100 | 0% | held | |
| 43 | MNLOUSD VYNE THERAPEUTICS INC | 0.7% | $731.2k | 462,801 | 31% | added | |
| 44 | ESTA ESTABLISHMENT LABS HLDGS INC | Healthcare | 0.5% | $534.5k | 13,100 | 0% | held |
| 45 | BCRX BIOCRYST PHARMACEUTICALS INC | Healthcare | 0.4% | $454.5k | 60,600 | – | new |
| 46 | ELDN ELEDON PHARMACEUTICALS INC | 0.3% | $387.0k | 114,145 | -55% | reduced | |
| 47 | AKBA AKEBIA THERAPEUTICS INC | Healthcare | 0.3% | $363.0k | 189,087 | -8% | reduced |
| 48 | NUVB NUVATION BIO INC | Healthcare | 0.2% | $169.5k | 96,311 | – | new |
| 49 | APRE APREA THERAPEUTICS INC | 0.1% | $59.1k | 28,972 | -77% | reduced |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.